IGC Pharma IGC
NYSE IGC
$0.27 +0.00 (+0.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

IGC Pharma (IGC) EBT (2010 - 2026)

Updated

IGC Pharma's EBT was -$2.4 million in FY2026, compared with -$7.12 million in FY2025.

Analysis

IGC Pharma (IGC) EBT (2010 - 2026) Analysis & Trends

From FY2011 onward, IGC Pharma has reported EBT for 16 years.

  • The FY2026 figure marks the highest annual EBT since FY2018.
  • Per Business Quant data, EBT in earlier years was -$7.12 million in FY2025, -$13 million in FY2024, -$11.51 million in FY2023 and -$15.02 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 6.75 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 4.28 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 2.80 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -10.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.39 Bn
10 IGC Pharma 26.67 Mn 23.92 Mn 55,000.00 -2.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.40 Mn
Sep 30, 2025 -1.82 Mn
Jun 30, 2025 -1.60 Mn
Mar 31, 2025 -1.20 Mn
Dec 31, 2024 -1.83 Mn
Sep 30, 2024 -1.72 Mn
Jun 30, 2024 -2.38 Mn
Mar 31, 2024 -2.89 Mn
Dec 31, 2023 -5.59 Mn
Sep 30, 2023 -2.45 Mn
Jun 30, 2023 -2.08 Mn
Mar 31, 2023 -4.03 Mn
Dec 31, 2022 -2.25 Mn
Sep 30, 2022 -2.44 Mn
Jun 30, 2022 -2.79 Mn
Mar 31, 2022 -6.50 Mn
Dec 31, 2021 -2.38 Mn
Sep 30, 2021 -4.34 Mn
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -2.95 Mn
API Access

IGC Pharma EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=IGC&period=max&api_key=YOUR_API_KEY